FindTrial
Sign In

Effectiveness and safety of quadruple therapy containing bismuth combined with Jinghua Weikang capsule in the treatment of Helicobacter pylori positive dyspepsia, a multicenter randomized controlled clinical trial

A multicenter, randomized, controlled clinical trial of quadruple therapy containing bismuth combined with Jinghua Weikang capsule in the treatment of Helicobacter pylori positive dyspepsia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17014072
Enrollment
Unknown
Registered
2017-12-21
Start date
2017-12-20
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hp infection related dyspepsia

Interventions

Group A:quadruple therapy containing bismuth
Group B:Jinghua Weikang capsule combined with quadruple therapy containing bismuth

Sponsors

First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Be confirmed Hp positive initial treatment of dyspepsia patients; (2) Be Han-Chinese healthy adults, men and women aged 18-60 years; (3) All patients diagnosed with by endoscopic examination; (4) No anti-hp drugs, antibiotics and microecological preparations have been used in the past four weeks; (5) All the candidates have informed consent.

Exclusion criteria

Exclusion criteria: (1) pregnancy, lactation or uncooperative patients; (2) Have severe hypertension, diabetes, coronary heart disease and other internal diseases; (3) Previous gastrointestinal surgery; (4) Have history of drug allergy.

Design outcomes

Primary

MeasureTime frame
H.pylori eradication rate;—

Secondary

MeasureTime frame
gastric inflammation;clinical symptoms;—

Countries

China

Contacts

Public ContactLv Bin

First Affiliated Hospital of Zhejiang Chinese Medical University

lvbin@medmail.com+86 13906515409

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026